Active, Not Recruiting
An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric Cancer
NCT04745988
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
- Locations
-
- National Cancer Center Hospital East Kashiwa, Chiba, Japan